424 related articles for article (PubMed ID: 22337949)
41. Elimination of hepatitis C virus has limited impact on the functional and mitochondrial impairment of HCV-specific CD8+ T cell responses.
Aregay A; Owusu Sekyere S; Deterding K; Port K; Dietz J; Berkowski C; Sarrazin C; Manns MP; Cornberg M; Wedemeyer H
J Hepatol; 2019 Nov; 71(5):889-899. PubMed ID: 31295532
[TBL] [Abstract][Full Text] [Related]
42. Hepatitis C virus-specific cytotoxic T cell response restoration after treatment-induced hepatitis C virus control.
Larrubia JR; Moreno-Cubero E; Miquel J; Sanz-de-Villalobos E
World J Gastroenterol; 2015 Mar; 21(12):3480-91. PubMed ID: 25834312
[TBL] [Abstract][Full Text] [Related]
43. T cell dysfunction by hepatitis C virus core protein involves PD-1/PDL-1 signaling.
Yao ZQ; King E; Prayther D; Yin D; Moorman J
Viral Immunol; 2007; 20(2):276-87. PubMed ID: 17603844
[TBL] [Abstract][Full Text] [Related]
44. Factors that determine the antiviral efficacy of HCV-specific CD8(+) T cells ex vivo.
Seigel B; Bengsch B; Lohmann V; Bartenschlager R; Blum HE; Thimme R
Gastroenterology; 2013 Feb; 144(2):426-436. PubMed ID: 23142136
[TBL] [Abstract][Full Text] [Related]
45. Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicity.
Rollier CS; Paranhos-Baccala G; Verschoor EJ; Verstrepen BE; Drexhage JA; Fagrouch Z; Berland JL; Komurian-Pradel F; Duverger B; Himoudi N; Staib C; Meyr M; Whelan M; Whelan JA; Adams VC; Larrea E; Riezu JI; Lasarte JJ; Bartosch B; Cosset FL; Spaan WJ; Diepolder HM; Pape GR; Sutter G; Inchauspe G; Heeney JL
Hepatology; 2007 Mar; 45(3):602-13. PubMed ID: 17326154
[TBL] [Abstract][Full Text] [Related]
46. HCV-specific T cells in HCV/HIV co-infection show elevated frequencies of dual Tim-3/PD-1 expression that correlate with liver disease progression.
Vali B; Jones RB; Sakhdari A; Sheth PM; Clayton K; Yue FY; Gyenes G; Wong D; Klein MB; Saeed S; Benko E; Kovacs C; Kaul R; Ostrowski MA
Eur J Immunol; 2010 Sep; 40(9):2493-505. PubMed ID: 20623550
[TBL] [Abstract][Full Text] [Related]
47. Restoration of HCV-specific CD8+ T cell function by interferon-free therapy.
Martin B; Hennecke N; Lohmann V; Kayser A; Neumann-Haefelin C; Kukolj G; Böcher WO; Thimme R
J Hepatol; 2014 Sep; 61(3):538-43. PubMed ID: 24905492
[TBL] [Abstract][Full Text] [Related]
48. Hepatitis C virus-specific cellular immune responses in sustained virological responders with viral persistence in peripheral blood mononuclear cells.
Roque-Cuéllar MC; Sánchez B; García-Lozano JR; Praena-Fernández JM; Márquez-Galán JL; Núñez-Roldán A; Aguilar-Reina J
Liver Int; 2014 Jul; 34(6):e80-8. PubMed ID: 24127783
[TBL] [Abstract][Full Text] [Related]
49. CD161 expression on hepatitis C virus-specific CD8+ T cells suggests a distinct pathway of T cell differentiation.
Northfield JW; Kasprowicz V; Lucas M; Kersting N; Bengsch B; Kim A; Phillips RE; Walker BD; Thimme R; Lauer G; Klenerman P
Hepatology; 2008 Feb; 47(2):396-406. PubMed ID: 18219672
[TBL] [Abstract][Full Text] [Related]
50. High-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infection.
Rutebemberwa A; Ray SC; Astemborski J; Levine J; Liu L; Dowd KA; Clute S; Wang C; Korman A; Sette A; Sidney J; Pardoll DM; Cox AL
J Immunol; 2008 Dec; 181(12):8215-25. PubMed ID: 19050238
[TBL] [Abstract][Full Text] [Related]
51. Effects of antiviral therapy on the cellular immune response in acute hepatitis C.
Rahman F; Heller T; Sobao Y; Mizukoshi E; Nascimbeni M; Alter H; Herrine S; Hoofnagle J; Liang TJ; Rehermann B
Hepatology; 2004 Jul; 40(1):87-97. PubMed ID: 15239090
[TBL] [Abstract][Full Text] [Related]
52. Analysis of a successful HCV-specific CD8+ T cell response in patients with recurrent HCV-infection after orthotopic liver transplantation.
Gruener NH; Jung MC; Ulsenheimer A; Gerlach JT; Zachoval R; Diepolder HM; Baretton G; Schauer R; Pape GR; Schirren CA
Liver Transpl; 2004 Dec; 10(12):1487-96. PubMed ID: 15558593
[TBL] [Abstract][Full Text] [Related]
53. Virus-Specific CD4+ T Cells Have Functional and Phenotypic Characteristics of Follicular T-Helper Cells in Patients With Acute and Chronic HCV Infections.
Raziorrouh B; Sacher K; Tawar RG; Emmerich F; Neumann-Haefelin C; Baumert TF; Thimme R; Boettler T
Gastroenterology; 2016 Mar; 150(3):696-706.e3. PubMed ID: 26584604
[TBL] [Abstract][Full Text] [Related]
54. Priming of Antiviral CD8 T Cells without Effector Function by a Persistently Replicating Hepatitis C-Like Virus.
Hartlage AS; Walker CM; Kapoor A
J Virol; 2020 May; 94(10):. PubMed ID: 32102885
[TBL] [Abstract][Full Text] [Related]
55. Patient-derived hepatitis C virus inhibits CD4⁺ but not CD8⁺ T lymphocyte proliferation in primary T cells.
MacParland SA; Chen AY; Corkum CP; Pham TN; Michalak TI
Virol J; 2015 Jun; 12():93. PubMed ID: 26084511
[TBL] [Abstract][Full Text] [Related]
56. Chronic genotype 1 hepatitis C along with cirrhosis drives a persistent imprint in virus-specific CD8
Perpiñán E; Pérez-Del-Pulgar S; Londoño MC; Mariño Z; Lens S; Leonel T; Bartres C; García-López M; Rodriguez-Tajes S; Forns X; Koutsoudakis G
J Viral Hepat; 2020 Dec; 27(12):1408-1418. PubMed ID: 32812325
[TBL] [Abstract][Full Text] [Related]
57. Dynamic Changes in Ex Vivo T-Cell Function After Viral Clearance in Chronic HCV Infection.
Han JW; Sung PS; Kim KH; Hong SH; Shin EC; Jun Song M; Park SH
J Infect Dis; 2019 Sep; 220(8):1290-1301. PubMed ID: 31152667
[TBL] [Abstract][Full Text] [Related]
58. Transient CD86 expression on hepatitis C virus-specific CD8+ T cells in acute infection is linked to sufficient IL-2 signaling.
Radziewicz H; Ibegbu CC; Hon H; Bédard N; Bruneau J; Workowski KA; Knechtle SJ; Kirk AD; Larsen CP; Shoukry NH; Grakoui A
J Immunol; 2010 Mar; 184(5):2410-22. PubMed ID: 20100932
[TBL] [Abstract][Full Text] [Related]
59. Impaired hepatitis C virus (HCV)-specific effector CD8+ T cells undergo massive apoptosis in the peripheral blood during acute HCV infection and in the liver during the chronic phase of infection.
Radziewicz H; Ibegbu CC; Hon H; Osborn MK; Obideen K; Wehbi M; Freeman GJ; Lennox JL; Workowski KA; Hanson HL; Grakoui A
J Virol; 2008 Oct; 82(20):9808-22. PubMed ID: 18667503
[TBL] [Abstract][Full Text] [Related]
60. Full-breadth analysis of CD8+ T-cell responses in acute hepatitis C virus infection and early therapy.
Lauer GM; Lucas M; Timm J; Ouchi K; Kim AY; Day CL; Schulze Zur Wiesch J; Paranhos-Baccala G; Sheridan I; Casson DR; Reiser M; Gandhi RT; Li B; Allen TM; Chung RT; Klenerman P; Walker BD
J Virol; 2005 Oct; 79(20):12979-88. PubMed ID: 16189000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
